| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
| 1. | Diabetic Neuropathies (Diabetic Neuropathy)
08/01/1995
- "Improvement in blood flow and diabetic neuropathy by thromboxane A2 dual blocker KDI-792."
Get all the results and reference details, order at left... |
| 2. | Diabetic Retinopathy (Retinopathy, Diabetic)
01/01/1996
- "To clarify the involvement of the prostaglandin (PG)-thromboxane (TX) system in diabetic retinopathy, the production of thromboxane A2 (TXA2), prostaglandin I2 (PGI2) and prostaglandin E2 (PGE2) and the effects of a thromboxane synthase inhibitor (TXSI; KDI-792; 5Z-6[(2S,4R)-4-(4-chlorophenylsulfonylamino)-1-(3-pyridyl methyl)-2 pyrrolidinyl]-5-hexenoic acid hydrochloride) were examined under high glucose concentration using bovine retinal endothelial cells"
Get all the results and reference details, order at left... |
| 2 Diseases and 2 more articles analyzed in the Research Interface, order at left... | |
| 1. | Thromboxane A2 (A2, Thromboxane)
|
| 2. | Dinoprostone (PGE2)
|
| 3. | Retinaldehyde (Retinal)
|
| 4. | Epoprostenol (Prostacyclin)
|
| 5. | Glucose (Dextrose)
|
| 5 Drugs and Important Bio-Agents and 2 more articles analyzed in the Research Interface, order at left... | |
| Price: | $490.00 access via web interface, 1 year subscription |
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |